This was a sub-study based upon banked blood of the REVERSAL trial.
这是一个源于REVERSAL试验库存血的分支研究。
Dr Ira Pastor, the CEO of Bioquark Inc. said: "This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime."
公司执行总裁艾拉·帕斯特博士说:“这是人类首次进行此类实验,是我们在有生之年逆转死亡的又一次尝试。”
应用推荐